Upfront Bevacizumab/témozolomide for Gliomastomas With Neurological Impairment
NCT03623347
·
clinicaltrials.gov ↗
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Chemoradiotherapy
Interventions
OTHER:
TMZ and BEV induction before chemoradiotherapy
Sponsor
Centre Hospitalier Universitaire, Amiens